442 related articles for article (PubMed ID: 28603178)
21. Adipocytokines in relation to cardiovascular disease.
Van de Voorde J; Pauwels B; Boydens C; Decaluwé K
Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981
[TBL] [Abstract][Full Text] [Related]
22. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.
Samaras K; Botelho NK; Chisholm DJ; Lord RV
Obesity (Silver Spring); 2010 May; 18(5):884-9. PubMed ID: 20019678
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular risk of adipokines: a review.
Dutheil F; Gordon BA; Naughton G; Crendal E; Courteix D; Chaplais E; Thivel D; Lac G; Benson AC
J Int Med Res; 2018 Jun; 46(6):2082-2095. PubMed ID: 28974138
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
25. Adipokines: a review of biological and analytical principles and an update in dogs, cats, and horses.
Radin MJ; Sharkey LC; Holycross BJ
Vet Clin Pathol; 2009 Jun; 38(2):136-56. PubMed ID: 19392760
[TBL] [Abstract][Full Text] [Related]
26. Adipokines and cardiovascular disease: A comprehensive review.
Smekal A; Vaclavik J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):31-40. PubMed ID: 28228651
[TBL] [Abstract][Full Text] [Related]
27. Adipokines in neurovascular diseases.
Opatrilova R; Caprnda M; Kubatka P; Valentova V; Uramova S; Nosal V; Gaspar L; Zachar L; Mozos I; Petrovic D; Dragasek J; Filipova S; Büsselberg D; Zulli A; Rodrigo L; Kruzliak P; Krasnik V
Biomed Pharmacother; 2018 Feb; 98():424-432. PubMed ID: 29278852
[TBL] [Abstract][Full Text] [Related]
28. Obesity: the 'huge' problem in cardiovascular diseases.
Ashraf MJ; Baweja P
Mo Med; 2013; 110(6):499-504. PubMed ID: 24564002
[TBL] [Abstract][Full Text] [Related]
29. Adipose-Vascular Coupling and Potential Therapeutics.
Gollasch M
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():417-436. PubMed ID: 27732801
[TBL] [Abstract][Full Text] [Related]
30. [Adipokines: adiponectin, leptin, resistin and coronary heart disease risk].
Kopff B; Jegier A
Przegl Lek; 2005; 62 Suppl 3():69-72. PubMed ID: 16521924
[TBL] [Abstract][Full Text] [Related]
31. Modulation of cardiovascular function by adipokines.
DeClercq V; Enns JE; Yeganeh A; Taylor CG; Zahradka P
Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):59-72. PubMed ID: 22882074
[TBL] [Abstract][Full Text] [Related]
32. Adipokines in inflammation, insulin resistance and cardiovascular disease.
Li ZY; Wang P; Miao CY
Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):888-96. PubMed ID: 21910745
[TBL] [Abstract][Full Text] [Related]
33. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides.
Seven E
Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487
[TBL] [Abstract][Full Text] [Related]
34. [Pathophysiological characterization of metabolic syndrome in overweight, obese and type 2 diabetic Algerian subjects: interest of adipokines as dysmetabolic biomarkers].
Benbaibeche H; Haffaf el M; Kacimi G; Oudjit B; Koceir E
Ann Biol Clin (Paris); 2014; 72(4):463-72. PubMed ID: 25119805
[TBL] [Abstract][Full Text] [Related]
35. Potential beneficial effect of some adipokines positively correlated with the adipose tissue content on the cardiovascular system.
Sawicka M; Janowska J; Chudek J
Int J Cardiol; 2016 Nov; 222():581-589. PubMed ID: 27513655
[TBL] [Abstract][Full Text] [Related]
36. Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions.
de Oliveira Dos Santos AR; de Oliveira Zanuso B; Miola VFB; Barbalho SM; Santos Bueno PC; Flato UAP; Detregiachi CRP; Buchaim DV; Buchaim RL; Tofano RJ; Mendes CG; Tofano VAC; Dos Santos Haber JF
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807959
[TBL] [Abstract][Full Text] [Related]
37. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome.
Odrowaz-Sypniewska G
Adv Med Sci; 2007; 52():246-50. PubMed ID: 18217426
[TBL] [Abstract][Full Text] [Related]
38. Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury.
Tian Z; Miyata K; Tazume H; Sakaguchi H; Kadomatsu T; Horio E; Takahashi O; Komohara Y; Araki K; Hirata Y; Tabata M; Takanashi S; Takeya M; Hao H; Shimabukuro M; Sata M; Kawasuji M; Oike Y
J Mol Cell Cardiol; 2013 Apr; 57():1-12. PubMed ID: 23333801
[TBL] [Abstract][Full Text] [Related]
39. Vascular biology of metabolic syndrome.
Vykoukal D; Davies MG
J Vasc Surg; 2011 Sep; 54(3):819-31. PubMed ID: 21439758
[TBL] [Abstract][Full Text] [Related]
40. Adipokines in diabetes and cardiovascular diseases.
Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
